
EXCLUSIVE I was training for my fourth marathon at 39... hit then diagnosed with a deadly cancer exploding among young people
The 39-year-old New Yorker had just run her fourth 26.2-mile marathon, and was avoiding alcohol and even eating clean. She felt unstoppable.
But just a month after the race in 2021, she was hit with a devastating diagnosis of stage four appendiceal cancer and told she had hundreds of tumors scattered over her insides.
'I had never even heard of this cancer,' Barad told DailyMail.com in an exclusive sit-down interview.
'I didn't know it was possible. I was really, really shocked. I had no other symptoms; I just thought this was some kind of endometriosis, something like that.'
Appendiceal cancer, or appendix cancer, is now the fastest-rising cancer among under-50s, with young adults today being up to seven times more likely to develop the disease as in the 1940s.
Barad is among the latest young adults to be diagnosed with the disease and, like many others, said she has no idea why she developed it, despite her healthy lifestyle.
She also has no idea when it started. She had heavy periods, menstrual cramps and bloating for as long as she could remember, which can be symptoms of appendicceal cancer, but had always played them down as normal.
VID HERE PLEASE PUT LIVE: 3477873
Doctors had dismissed them too, saying they were 'just something women go through' and putting her on birth control and over-the-counter painkillers to reduce her symptoms.
But in late 2021, after she changed gynecologist, Barad was recommended for an ultrasound on the pretence of getting an IUD, or small T-shaped device that is inserted into the uterus to prevent pregnancy.
The scan revealed a grapefruit-sized cyst on her right ovary, despite the fact that ovaries are only about three to five centimeters long. This was also very large for Barad, who is just 5ft 1in tall.
She was rushed into surgery, but during the procedure doctors noted a strange mucus in her abdominal cavity and that her appendix was swollen.
They removed her appendix and sent it for testing, along with her cyst, right ovary and right fallopian tube.
A few weeks later, in December 2021, she was called back into her doctor's office to be given the diagnosis.
Barad said: 'It's hard to figure out when was that quote-unquote normal [menstrual cramps] versus when did I have appendix cancer, and that was what was making the symptoms.
'What was a red flag symptom was close to my diagnosis I had to urinate a lot, and I would notice every time I would drink something I would have to use the bathroom. I always felt the need to pee.
'And it turned out that was because I had a huge ovarian cyst and it was taking up space where my bladder is and that was me needing to urinate.'
Appendiceal cancer has no clear symptoms, especially in its early stages, meaning doctors often struggle to diagnose the disease.
It is rare, with about 3,000 cases every year, and normally diagnosed in people around 50 and 55 years old.
But as cases have risen among younger adults, researchers have suggested that shifts in the microbiome caused by the western diet could be raising the risk of developing the cancer.
This is also one of the leading theories linked to a surge in colon cancer in young people.
There are several types of the cancer, but Barad was diagnosed with low-grade appendiceal mucinous neoplasm (LAMN), a rare and slow-growing form where cells in the appendix overproduce mucin — a jelly-like substance — that can flood the abdominal cavity and push other cells into it.
This disruption in the body's internal cavity can cause a large cyst to develop on an ovary, like in Barad's case, or on another organ of the body.
It isn't clear how often this form of the disease affects patients, but some studies on only a small number of patients have suggested it is around 40 percent of all cases.
To treat her cancer, Barad was brought in for a major 12-hour surgery in March 2022 to try to clear the disease from her body.
For the procedure, surgeons initially made an incision from her chest to her pelvis and opened up her body, before trying to remove as much of mucin as possible that was coating each organ.
They removed part of her liver, omentum - the thin tissue surrounding the stomach - and part of her diaphragm during the surgery because these were covered in mucin.
Doctors also said they might have to remove her uterus, leaving Barad unable to start a family, but managed to save the organ.
Then, doctors pumped her abdominal cavity full of chemotherapy drugs heated to 106F (41C), sewed her up and rotated her for about 90 minutes. She was rotated to spread the chemotherapy drugs in her abdomen to treat any remaining cancer cells.
The drugs were then extracted, and Barad said she went through months of a 'miserable' recovery where she was so unwell she was barely able to leave the apartment.
But the surgery was a success, and the cancer has not been detected in Barad since. She now returns every year to the hospital to check for recurrence.
Appendix cancer is slow-growing, however, with Barad saying that she will never be considered 'cured,' just 'in remission' because of the risk more cancerous cells could appear.
She said: 'It's so slow moving, it could be slowly growing over the next couple of years, so it's uncertain.
'But every year now I get scans and blood work done and I feel like I am just in really good hands with all of this.'
Survival rates for appendix cancer vary widely depending on the type and how advanced the cancer is, with between 67 and 97 percent of patients living for longer than five years after their diagnosis.
For LAMN, about 64 percent of patients survive for longer than five years according to studies.
Amid her recovery, Barad said she is now trying to live an intentional life and is thankful for the people around her and aiming to raise awareness about the disease.
She lives in her apartment with her dog Charlie, a rescued Maltese poodle mix, and keeps active with long hikes.
She also had her eggs frozen at age 35 in case she wanted to start a family but now says she doesn't think she wants to put her body through the trial of pregnancy.
Barad is thankful that her cancer was slow growing but fears the outcome if it had not been detected earlier.
She was helped through her journey by PMP Pals and the Abdominal Cancers Alliance, which aim to help patients with the disease.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
24 minutes ago
- The Guardian
RFK Jr to remove preservative thimerosal from all US vaccines
Robert F Kennedy Jr, the US health secretary, will formally require vaccine makers to remove thimerosal from vaccines. The ingredient has been the target of anti-vaccine campaigns and misinformation for decades. Arguments against the preservative culminated in June, when a key federal vaccine advisory panel, remade with Kennedy's ideological allies, recommended against the preservative. The recommendation goes into force upon Kennedy's signature. There is no evidence thimerosal has caused harm, despite decades of use. The ethylmercury-based preservative was used in only about 5% adult influenza vaccines in the US, helping prevent contamination in multi-dose vials. 'After more than two decades of delay, this action fulfills a long-overdue promise to protect our most vulnerable populations from unnecessary mercury exposure,' Kennedy said in a statement announcing the decision. 'Injecting any amount of mercury into children when safe, mercury-free alternatives exist defies common sense and public health responsibility. Today, we put safety first,' said Kennedy. Thimerosal is an ethylmercury-based preservative – different from the kind of mercury found in seafood, called methylmercury. Ethylmercury has a shorter half-life in the body. The amount of ethylmercury contained in a flu vaccine (25 micrograms) is about half of that contained in a 3oz serving of canned tuna fish (40 micrograms). The preservative has been used in vaccines since before the second world war. It was controversially phased out of most childhood vaccines in 1999, physicians associations said as a precautionary measure, and was contained in only a very small number of adult vaccines. Phasing out the preservative in the early 2000s was criticized by experts who argued scientific evidence did not support its removal, that it sent mixed messages and that it provided a talking point for anti-vaccine campaigners. Indeed, the preservative was targeted for years to come. That criticism came to a head in June, after Kennedy fired all 17 members of the Centers for Disease Control and Prevention's (CDC) advisory committee on immunization practices, a federal panel that was a critical link in the vaccine distribution pipeline. Kennedy replaced the experts with eight hand-picked allies, including one directly from the anti-vaccine movement. Eventually, one appointee dropped out after a conflict of interest review. The vaccine advisory panel voted in favor of removing thimerosal on a 5-1 vote (with one abstention) after a controversial presentation from Lyn Redwood, a former leader of World Mercury Project, the predecessor to Kennedy's group Children's Health Defense, itself a prolific anti-vaccine campaign group. Redwood's presentation had to be updated after it was found to contain a link to a study that did not exist. One of Kennedy's vaccine advisers said during the meeting that a presentation from career scientists at the CDC, which laid out thimerosal's safety, was pulled by the secretary's office. The director of the CDC is required to sign off on the vaccine advisory committee's recommendations. Because there is not presently a Senate-confirmed CDC director, Kennedy acts as head of the CDC. The decision to remove thimerosal from all vaccines in the US will also probably complicate the global picture for vaccine makers. 'With the US now removing mercury from all vaccines, we urge global health authorities to follow this prudent example for the protection of children worldwide,' Kennedy said.


Daily Mail
37 minutes ago
- Daily Mail
Doctors dismissed woman's common symptoms for months... until they discovered she had a deadly colon cancer
A Pennsylvania woman was diagnosed with deadly cancer after being dismissed by doctors. Rylie Toomey, 27, was in the midst of planning her wedding and training for a half marathon when she was struck with unbearable abdominal pain in October 2024. She rushed to the hospital, where doctors performed a CT scan and insisted she was just constipated before sending her home. Doctors told her the same thing when she returned every few months for testing, until she ended up in the emergency department screaming in pain this past April. She was also suffering from a fever. She said: 'In my head I was like, I think I'm going to die - that's how much pain I was in. 'I felt like I was being stabbed, and my belly was super bloated, too. It felt like I was just going to explode.' Toomey had suffered a perforated bowel, meaning there was a hole in her intestinal wall. During that hospital visit, another CT scan detected stage four colon cancer that had spread to her liver and lungs - and she became one of the thousands of young Americans who have been diagnosed with colorectal cancer despite living healthy lives. Toomey told 'When you hear, "You have cancer," you're just like, that can't be right. That can't be me because leading up to this, I was so healthy. 'To hear that I had colon cancer just didn't make sense, just because you feel like colon cancer is linked to unhealthy people or people who eat unhealthy or the elderly. 'I just was not expecting that at all.' The American Cancer Society estimates over 154,000 Americans will be stuck by colorectal cancer this year, including about 20,000 under 50. While this is roughly in line with two decades ago, the disease is rising sharply in younger groups. From 1999 to 2018, the rate of colorectal cancer in the under-50 population rose from 8.6 cases per 100,000 people to 13 cases per 100,000 people. Colorectal cancer diagnoses in 20- to 34-year-olds is set to increase by 90 percent between 2010 and 2030, and rates for teenagers have surged 500 percent since the early 2000s. Lifestyle factors like diet, lack of exercise and a sedentary lifestyle have all been blamed, though these causes fail to explain why physically fit people like Toomey have increasingly been diagnosed with colorectal cancer. The latest evidence, published in April, also suggests childhood exposure to a toxin released by E. coli bacteria could increase the risk of colorectal cancer by triggering inflammation and altering the balance of the gut microbiome. Marijuana was also linked to colorectal cancer in a recent study, as it is thought to block tumor-suppressing cells. Toomey told that she regularly plays lacrosse, runs and cycles and sticks to a healthy diet. She also has no family history of colon cancer. About one in five colorectal cancer patients are diagnosed like Toomey, after a bowel-related emergency often caused by the tumor growing, recent research shows. Toomey is now receiving chemotherapy every two weeks and regular immunotherapy infusions, with eight treatments left. Treatment forced her to push back her wedding, which was supposed to take place last month, and schedule it for June 2026. She said: 'It's definitely something that keeps me going right now. It's kind of hard to stay positive in situations like this, but this is something that's bringing me joy and keeping me going.' Friends have set up a GoFundMe page for medical expenses. Toomey is also urging other young people with symptoms to get checked out immediately and push for answers, even if doctors are dismissive. She said: 'I just don't want anybody to ever go through something like this. I think this happened for a reason so I can help others.'


Daily Mail
37 minutes ago
- Daily Mail
Common virus that affects 124million Americans may contribute to debilitating multiple sclerosis
About one in two adults is infected with a virus that can cause cold sores, fever and blisters in the mouth. But now, researchers at the University of Illinois Chicago (UIC) suggest that oral herpes, caused by herpes simplex virus-1 (HSV-1), could also raise the risk of suffering from the life-altering condition multiple sclerosis. In a new study, scientists gene-edited mice not to produce a protein called optineurin, which plays a role in defending the body against herpes infections, and then infected the mice with the virus. The infection led to the rapid degradation of the myelin sheath, a protective coating on nerve fibers. This caused mice to suffer MS-like symptoms, such as muscle weakness, loss of movement and the ability to coordinate muscles. This mirrors the process observed in individuals with multiple sclerosis, where the myelin sheath also degrades because the immune system misfires and starts to attack the area. The scientists say their findings could indicate a link between HSV-1, which is different from the HSV-2 virus that causes genital herpes, and MS. Dr Deepak Shukla, a professor of molecular virology at UIC and the study's lead, said: 'Our findings enhance our understanding of how viruses develop and offer potential avenues for mitigating viral-induced [nerve cell] damage. 'If you are infected, then your immune system is constantly locked in battle with the virus. And if for any reason you become immunocompromised, the virus can escape and damage your brain.' Oral herpes is an extremely common condition that infects about 47 percent of adults, according to the CDC, or 124million people. The virus is spread via sexual contact, such as kissing and oral sex, and is incurable, normally lying dormant and triggering occasional flare-ups of sores on and around the mouth and lips. In cells, it is controlled by the protein optineurin, which stops an infection from spreading and protects against any potential myelin sheath damage. Scientists have previously established that one of the biggest risk factors for MS is an infection with the Epstein-Barr virus (EBV), a virus that has infected 95 percent of adults and which is estimated to raise the risk of MS by 30 percent. And other herpes viruses, like the ones that cause chickenpox, shingles, and human herpes virus 6, have also been linked to the onset and worsening of MS, which affects 1 million Americans. And MS is a debilitating, incurable autoimmune condition that affects the brain and spinal cord and leaves people with mobility issues, memory loss and fatigue. In earlier studies, Dr Shukla's team found that HSV-1 triggered a strong immune response in the brains of mice, causing memory problems, poor coordination, and anxiety. They also discovered that the protein optineurin helps fight the virus by slowing its growth and spread. In the latest study, researchers infected mice that could not produce the protein with the oral herpes virus in their eyes. As seen in earlier cell tests, mice without optineurin had higher infection rates after four days. The researchers also found that a protein called MLKL, or Mixed Lineage Kinase Domain-Like protein, which is made by the body during cell death, boosted HSV-1 infections in the absence of optineurin. Researchers said the protein facilitated the transportation of the virus into a cell's nucleus, speeding an infection, and optineurin controlled HSV-1 infection by triggering the deterioration of MLKL. Imaging studies revealed extensive clumping, or aggregation, of MLKL in the brains of optineurin-lacking mice, but not in control mice, in response to HSV-1 infection. Also, these clumps appeared to trigger the death of myelin-producing oligodendrocytes, or cells that create armor, or the myelin sheath, around neurons. Without the sheath, the nervous system was left vulnerable to damage. The resulting damage disrupts the communication between the brain and the rest of the body, leading to the various symptoms associated with MS, such as weakness in the legs, fatigue, coordination problems, cognitive changes, and pain. Identifying this protein offers a new target for multiple sclerosis therapies. Already, Shukla's lab has demonstrated that necrosulfonamide, which inhibits optineurin, can preserve nerve function in animal models. Studies like these provide hope for the future of MS, and bring about the potential to enable earlier intervention or a possible cure.